A detailed history of Royal Bank Of Canada transactions in Neogenomics Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 39,060 shares of NEO stock, worth $671,050. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,060
Previous 31,878 22.53%
Holding current value
$671,050
Previous $442,000 30.32%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$13.4 - $17.73 $96,238 - $127,336
7,182 Added 22.53%
39,060 $576,000
Q2 2024

Aug 14, 2024

BUY
$13.01 - $15.77 $196,854 - $238,615
15,131 Added 90.35%
31,878 $442,000
Q1 2024

Nov 05, 2024

SELL
$14.06 - $16.79 $212,741 - $254,049
-15,131 Reduced 47.47%
16,747 $263,000
Q1 2024

May 15, 2024

SELL
$14.06 - $16.79 $425,427 - $508,031
-30,258 Reduced 64.37%
16,747 $263,000
Q4 2023

Feb 14, 2024

BUY
$11.67 - $20.73 $250,298 - $444,617
21,448 Added 83.92%
47,005 $760,000
Q3 2023

Nov 14, 2023

BUY
$12.15 - $17.85 $15,588 - $22,901
1,283 Added 5.29%
25,557 $314,000
Q2 2023

Aug 14, 2023

BUY
$14.1 - $19.83 $101,322 - $142,498
7,186 Added 42.05%
24,274 $390,000
Q1 2023

May 15, 2023

SELL
$9.09 - $19.45 $161,901 - $346,423
-17,811 Reduced 51.04%
17,088 $297,000
Q4 2022

Feb 14, 2023

BUY
$6.45 - $12.07 $110,714 - $207,181
17,165 Added 96.79%
34,899 $322,000
Q3 2022

Nov 14, 2022

SELL
$7.86 - $12.91 $16,230 - $26,659
-2,065 Reduced 10.43%
17,734 $152,000
Q2 2022

Aug 15, 2022

SELL
$7.06 - $13.97 $149,749 - $296,317
-21,211 Reduced 51.72%
19,799 $162,000
Q1 2022

May 16, 2022

BUY
$12.15 - $35.28 $130,989 - $380,353
10,781 Added 35.66%
41,010 $500,000
Q4 2021

Feb 14, 2022

BUY
$30.49 - $48.49 $388,076 - $617,180
12,728 Added 72.73%
30,229 $1.03 Million
Q3 2021

Nov 15, 2021

SELL
$41.66 - $52.52 $1.63 Million - $2.06 Million
-39,176 Reduced 69.12%
17,501 $844,000
Q2 2021

Aug 16, 2021

BUY
$36.62 - $51.69 $2.08 Million - $2.93 Million
56,677 New
56,677 $2.56 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.16B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.